Overview

The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497

Status:
Completed
Trial end date:
2019-03-21
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of CKD-497
Phase:
Phase 2
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical